TABLE 2.
Sample identifier | Serotype identifieda
|
|||||
---|---|---|---|---|---|---|
CSF
|
Pneumococcal suspension
|
|||||
PCR | Antigen capture
|
PCR | Antigen capture
|
|||
89-SF | MAbs | 89-SF | MAbs | |||
1 | ||||||
5b | 6A/6B | 1 | 1 | 6A/6B | 22F | |
7 | 19A | 19A | 1 | 1 | ||
9 | 6A/6B | 1 | Not tested | 6A/6B | 1 | 1 |
10 | 12F | 12F | 12F | 12F | ||
12 | 12F | 12F | 12F | 12F | ||
17 | 14 | No sample | No sample | 14 | 14 | 14 |
19 | 35B | 35B | ||||
21 | 6A/6B | 6A | 6A | 6A/6B | 6A | 6A |
22 | 19F | 19F | 19F | 19F | 19F | 19F |
25 | 6A/6B | 6B | 6B | 6A/6B | 6B | 6B |
26 | 8 | 8 | 8 | 8 | ||
28c | 5 | 5 | ||||
30 | 6A/6B | 1 | 1 | 6A/6B | 1 | 1 |
32 | 14 | 14 | 14 | 14 | No sample | No sample |
33 | 14 | 14 | 14 | 14 | ||
38 | 14 | 14 | 14 | 14 | No sample | No sample |
45 | 6A/6B | 6B | 6B | 6A/6B | 6B | 6B |
46 | 7F | 7F | 7F | 7F | ||
47 | 23F | 23F | 23F | |||
51 | 6A/6B | 6B | 6B | 6A/6B | No sample | No sample |
52 | 1 | 1 | 1 | 1 | 1 | 1 |
54 | 16F | 16F | ||||
55 | 23F | 23F | 23F | 23F | ||
59 | 1 | 1 | 1 | 1 | 1 | 1 |
60 | 6A/6B | 6B | 6B | 6A/6B | 6B | 6B |
65 | 6A/6B | 6B | 6B | 6A/6B | 6B | 6B |
66 | 23F | 23F | 23F | 23F | ||
69 | 23F | 23F | 23F | 23F | ||
72 | 23F | 23F | 23F | 23F | ||
77 | 1 | No sample | No sample | 1 | 1 | 1 |
78 | 23F | 23F | 23F | 23F | ||
79c,d | 6A/6B | 6A/6B | 6A/6B | 6A/6B | ||
80 | 23F | 23F | 23F | 23F | ||
81 | No growth | 9V/9N | No growth | 9V/9N | ||
82 | 1 | 1 | 1 | 1 | 1 | 1 |
90e | sg18 | 18C | sg18 | 18C | ||
93 | No growth | 6B | 6B | No growth | No sample | No sample |
95 | 1 | 1 | 1 | 1 | 1 | 1 |
97 | 1 | 1 | 1 | 1 | 1 | 1 |
104b | 12F | 12F | 12F | 5 | ||
105 | No growth | 14 | 14 | No growth | 14 | 14 |
107 | 15A | 15A | ||||
110 | No growth | 14 | 14 | No growth | 14 | 14 |
111 | 1 | 1 | 1 | 1 | 1 | 1 |
112 | sg18 | 18c | sg18 | 18C | ||
113 | 17F | 17F | 17F | 17F | ||
116 | No growth | 23F | No growth | No sample | ||
118 | ||||||
119 | 1 | 1 | 1 | 1 | 1 | 1 |
122 | No growth | 1 | Not tested | No growth | 1 | 1 |
126 | 35F | 35F | ||||
127 | No growth | 1 | Not tested | No growth | 1 | 1 |
138 | 16F | 16F | ||||
139 | ||||||
140 | 14 | 14 | 14 | 14 | 14 | 14 |
148 | 10A | 10A | ||||
150 | 6A/6B | 6A | 6A | 6A/6B | 6A | 6A |
153 | 6B | 6B | No sample | |||
155 | No sample | 23F | No growth | 23F | ||
159 | 4 | 4 | 4 | 4 | ||
161 | No growth | No growth | No sample | |||
162 | 1 | 1 | 1 | 1 | 1 | 1 |
Blank cell, no serotype detected.
Discrepancy between the serotype identified in CSF and that identified in the suspension.
No serotype was identified in the CSF.
Serotype 6A inhibition was greater than that of serotype 6B inhibition; no discrimination was achieved with the serotype 6A- and serotype 6B-specific MAbs.
The PCR assay determined only serogroup 18.